NO20010629L - FremgangsmÕte for fremstilling av en ikke-krystallinsk anhydratform av paroksetinhydroklorid - Google Patents

FremgangsmÕte for fremstilling av en ikke-krystallinsk anhydratform av paroksetinhydroklorid

Info

Publication number
NO20010629L
NO20010629L NO20010629A NO20010629A NO20010629L NO 20010629 L NO20010629 L NO 20010629L NO 20010629 A NO20010629 A NO 20010629A NO 20010629 A NO20010629 A NO 20010629A NO 20010629 L NO20010629 L NO 20010629L
Authority
NO
Norway
Prior art keywords
paroxetine hydrochloride
preparing
anhydrate form
crystalline anhydrate
propan
Prior art date
Application number
NO20010629A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010629D0 (no
Inventor
Victor Witold Jacewicz
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9817196.0A external-priority patent/GB9817196D0/en
Priority claimed from GBGB9828777.4A external-priority patent/GB9828777D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20010629D0 publication Critical patent/NO20010629D0/no
Publication of NO20010629L publication Critical patent/NO20010629L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20010629A 1998-08-07 2001-02-06 FremgangsmÕte for fremstilling av en ikke-krystallinsk anhydratform av paroksetinhydroklorid NO20010629L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9817196.0A GB9817196D0 (en) 1998-08-07 1998-08-07 Novel process
GBGB9828777.4A GB9828777D0 (en) 1998-12-29 1998-12-29 Novel compounds
PCT/GB1999/002592 WO2000008017A1 (en) 1998-08-07 1999-08-06 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride

Publications (2)

Publication Number Publication Date
NO20010629D0 NO20010629D0 (no) 2001-02-06
NO20010629L true NO20010629L (no) 2001-03-20

Family

ID=26314179

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010629A NO20010629L (no) 1998-08-07 2001-02-06 FremgangsmÕte for fremstilling av en ikke-krystallinsk anhydratform av paroksetinhydroklorid

Country Status (24)

Country Link
EP (2) EP1321465A3 (ja)
JP (1) JP2002522434A (ja)
KR (1) KR20010072323A (ja)
CN (1) CN1321155A (ja)
AP (2) AP2001002072A0 (ja)
AT (1) ATE239016T1 (ja)
AU (1) AU5428999A (ja)
BG (1) BG105310A (ja)
BR (1) BR9912858A (ja)
CA (1) CA2339857A1 (ja)
DE (1) DE69907467T2 (ja)
DK (1) DK1100796T3 (ja)
EA (1) EA200100221A1 (ja)
ES (1) ES2198940T3 (ja)
HK (1) HK1038230A1 (ja)
HU (1) HUP0105466A3 (ja)
ID (1) ID27914A (ja)
IL (1) IL141286A0 (ja)
NO (1) NO20010629L (ja)
PL (1) PL345885A1 (ja)
PT (1) PT1100796E (ja)
SK (1) SK1972001A3 (ja)
TR (1) TR200100444T2 (ja)
WO (1) WO2000008017A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1384720A1 (en) * 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Process for drying paroxetine hydrochloride
JP3796351B2 (ja) 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
ES2311561T3 (es) * 2000-11-17 2009-02-16 Eli Lilly And Company Dipeptido de lactama y su uso en la inhibicion de la liberacion del peptido beta amiloide.
EP2596792A1 (en) 2002-10-16 2013-05-29 Takeda Pharmaceutical Company Limited Stable solid preparations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
HUP0000960A3 (en) * 1997-01-15 2001-04-28 Smithkline Beecham Plc Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法

Also Published As

Publication number Publication date
TR200100444T2 (tr) 2001-07-23
WO2000008017A1 (en) 2000-02-17
EP1100796A1 (en) 2001-05-23
HUP0105466A2 (hu) 2002-05-29
PL345885A1 (en) 2002-01-14
EP1321465A3 (en) 2003-09-03
JP2002522434A (ja) 2002-07-23
AU5428999A (en) 2000-02-28
ES2198940T3 (es) 2004-02-01
KR20010072323A (ko) 2001-07-31
CN1321155A (zh) 2001-11-07
NO20010629D0 (no) 2001-02-06
DE69907467D1 (de) 2003-06-05
EP1100796B1 (en) 2003-05-02
ATE239016T1 (de) 2003-05-15
PT1100796E (pt) 2003-09-30
EA200100221A1 (ru) 2001-08-27
EP1321465A2 (en) 2003-06-25
HK1038230A1 (en) 2002-03-08
SK1972001A3 (en) 2001-08-06
HUP0105466A3 (en) 2002-11-28
CA2339857A1 (en) 2000-02-17
AP0102072A0 (en) 2001-02-06
BG105310A (en) 2001-12-29
BR9912858A (pt) 2001-11-20
AP2001002072A0 (en) 2001-03-31
IL141286A0 (en) 2002-03-10
ID27914A (id) 2001-05-03
DE69907467T2 (de) 2004-03-11
DK1100796T3 (da) 2003-08-25

Similar Documents

Publication Publication Date Title
DE59701369D1 (de) Thermisch härtbare, wässrige zusammensetzungen
MEP21908A (en) Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same
BG104842A (en) New hydroxyindoles, their use as phosphodiesterase 4 inhibitiors and methods for producing same
PT1129633E (pt) Barreira isolante termica antifogo, processo de fabrico de uma tal barreira, vestuario que compreende pelo menos uma tal barreira na qualidade de isolamento interno
DK0766668T3 (da) Fremgangsmåde til fremstilling af vandfrie og hydratformer af som antihistaminer anvendelige piperidinderivater, polymorfer og pseudo-morfer deraf
DE69709938D1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
DK159777C (da) N-alkyl-norscopiner og fremgangsmaade til fremstilling heraf samt deres anvendelse som mellemprodukter
DK0772604T3 (da) Trialzolforbindelser og deres anvendelse som dopamin-D3-ligander
NO20010629L (no) FremgangsmÕte for fremstilling av en ikke-krystallinsk anhydratform av paroksetinhydroklorid
DE69815302D1 (de) Glaszusammensetzung zur vermeidung der alkali-kiesel-kieselsäure reaktion
IL127929A0 (en) Use of novel glass compositions in preparing dental glass pillars and support pillars and method for producing the glass pillars
DK0783391T3 (da) Håndloddeværktøj
BR9714066A (pt) Processo para a preparação de derivados de tiazol.
NO920235L (no) Substituerte 1,2,3,4-tetrahydrocyklopent(b)indoler, 1,2,3,3a,4,8a-heksahydrocyklopent(b)indoler og beslektede forbindelser, mellomprodukter og en fremgangsmaate for fremstilling av disse og deres bruk som medikamenter
ZA962059B (en) Control of expansion in concrete due to alkali silica reaction
PT1303514E (pt) Processo para preparacao de azacicloalcanoilaminotiazoles
LV12733A (lv) A novel crystalline form of 6-hydroxy-3- (4-¬2-(piperidin-1-yl) ethoxy¾ phenoxy)-2-(4-methoxyphenyl) benzo ¬b¾ thiophene hydrochloryde
NZ333229A (ja)
BR0214578A (pt) Compostos azopolicìclicos fundidos com arila
NO20015202L (no) <beta>-Hydroksyalkylamider, fremgangsmåte for deres fremstilling og deres anvendelse
RU2001131192A (ru) Композиция для изготовления теплоизоляционного материала
DK0809627T3 (da) Hidtil ukendte borneolderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
NO964522D0 (no) Fremgangmåte ved fremstilling av 5,6-dihydroksy-2-amino-1,2,3,4-tetrahydronaftalenderivater
ATE262516T1 (de) Kristallines (-)-3r,4r-trans-7-methoxy-2,2-
DK0869957T3 (da) 3(2H)-Pyridazinonderivater og farmaceutiske sammensætninger indeholdende disse forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application